Home / Adalimumab / Austria
AT ATC L04AB04 · updated 2 Nov 2026
Adalimumab shortage in Austria
Is there an Adalimumab shortage in Austria?
Yes. As of 2 Nov 2026, 5 Adalimumab products are reported short in Austria, the first since 17 Jul 2025. The company estimate for the return is 30 Nov 2026 (latest 31 Mar 2027). Main reason: increased demand.
Also short in United States, Germany, Italy, Spain, Belgium, Czechia, Sweden. All countries.
Affected products in Austria
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Hukyndra 40 mg Injektionslösung im Fertigpen, 2 Stück limited | STADA Arzneimittel AG | 17 Jul 2025 | 30 Nov 2026 | Increased demand Erhöhter Mehrbedarf |
| AT | Hukyndra 80 mg Injektionslösung im Fertigpen, 1 Stück limited | STADA Arzneimittel AG | 1 Sep 2026 | 30 Nov 2026 | Increased demand Erhöhter Mehrbedarf |
| AT | Yuflyma 40 mg Injektionslösung im Fertigpen, 2 Stück limited | Celltrion Healthcare Hungary Ltd. | 22 Sep 2026 | 31 Mar 2027 | Increased demand Erhöhter Mehrbedarf |
| AT | Yuflyma 40 mg Injektionslösung in einer Fertigspritze, 2 Stück limited | Celltrion Healthcare Hungary Ltd. | 22 Sep 2026 | 31 Mar 2027 | Increased demand Erhöhter Mehrbedarf |
| AT | Yuflyma 80 mg Injektionslösung im Fertigpen, 1 Stück limited | Celltrion Healthcare Hungary Ltd. | 22 Sep 2026 | 31 Mar 2027 | Increased demand Erhöhter Mehrbedarf |
Source
BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).